Principles of clinically important drug interactions with carbamazepine. Part II.
Ketter
T A
TA
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892.
Post
R M
RM
Worthington
K
K
D002220:Carbamazepine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004347:Drug Interactions / Q000502:physiology*; D004359:Drug Therapy, Combination; D006801:Humans; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy* / Q000523:psychology
D002220:Carbamazepine